Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$40.06 - $59.44 $2.21 Million - $3.27 Million
-55,052 Reduced 4.83%
1,084,118 $61.7 Million
Q3 2022

Oct 14, 2022

SELL
$38.53 - $51.78 $14.9 Million - $20 Million
-387,123 Reduced 25.36%
1,139,170 $45 Million
Q2 2022

Jul 27, 2022

SELL
$37.35 - $48.3 $758,167 - $980,441
-20,299 Reduced 1.31%
1,526,293 $67.2 Million
Q1 2022

Apr 28, 2022

BUY
$31.97 - $41.06 $1.5 Million - $1.93 Million
47,016 Added 3.14%
1,546,592 $61.7 Million
Q4 2021

Jan 25, 2022

SELL
$31.82 - $40.75 $219,462 - $281,052
-6,897 Reduced 0.46%
1,499,576 $60.3 Million
Q3 2021

Oct 18, 2021

BUY
$38.47 - $46.42 $5.99 Million - $7.22 Million
155,603 Added 11.52%
1,506,473 $61.3 Million
Q2 2021

Jul 16, 2021

SELL
$38.84 - $51.31 $90,807 - $119,962
-2,338 Reduced 0.17%
1,350,870 $61.3 Million
Q1 2021

Apr 26, 2021

BUY
$39.51 - $51.45 $7.48 Million - $9.74 Million
189,327 Added 16.27%
1,353,208 $56.4 Million
Q4 2020

Jan 26, 2021

BUY
$25.81 - $43.62 $2.06 Million - $3.48 Million
79,866 Added 7.37%
1,163,881 $49.7 Million
Q3 2020

Nov 09, 2020

BUY
$25.74 - $29.63 $2.13 Million - $2.45 Million
82,568 Added 8.24%
1,084,015 $28.5 Million
Q2 2020

Aug 12, 2020

BUY
$16.25 - $26.81 $16.3 Million - $26.8 Million
1,001,447 New
1,001,447 $26.8 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Tran Capital Management, L.P. Portfolio

Follow Tran Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tran Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tran Capital Management, L.P. with notifications on news.